9cg0

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (10:29, 12 March 2025) (edit) (undo)
 
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 9cg0 is ON HOLD until Paper Publication
+
==Human DJ-1, 30 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography==
 +
<StructureSection load='9cg0' size='340' side='right'caption='[[9cg0]], [[Resolution|resolution]] 1.77&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[9cg0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9CG0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9CG0 FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.77&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1A7V:S-[(2S)-2-hydroxypropanoyl]-L-cysteine'>A1A7V</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9cg0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9cg0 OCA], [https://pdbe.org/9cg0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9cg0 RCSB], [https://www.ebi.ac.uk/pdbsum/9cg0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9cg0 ProSAT]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[https://www.uniprot.org/uniprot/PARK7_HUMAN PARK7_HUMAN] Defects in PARK7 are the cause of Parkinson disease type 7 (PARK7) [MIM:[https://omim.org/entry/606324 606324]. A neurodegenerative disorder characterized by resting tremor, postural tremor, bradykinesia, muscular rigidity, anxiety and psychotic episodes. PARK7 has onset before 40 years, slow progression and initial good response to levodopa. Some patients may show traits reminiscent of amyotrophic lateral sclerosis-parkinsonism/dementia complex (Guam disease).<ref>PMID:12851414</ref> <ref>PMID:12446870</ref> <ref>PMID:14713311</ref> <ref>PMID:12953260</ref> <ref>PMID:15365989</ref> <ref>PMID:14607841</ref> <ref>PMID:15254937</ref> <ref>PMID:17846173</ref>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/PARK7_HUMAN PARK7_HUMAN] Protects cells against oxidative stress and cell death. Plays a role in regulating expression or stability of the mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via L-type channels during pacemaking. Eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death. May act as an atypical peroxiredoxin-like peroxidase that scavenges hydrogen peroxide. Following removal of a C-terminal peptide, displays protease activity and enhanced cytoprotective action against oxidative stress-induced apoptosis. Stabilizes NFE2L2 by preventing its association with KEAP1 and its subsequent ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating activity. Enhances RELA nuclear translocation. Binds to a number of mRNAs containing multiple copies of GG or CC motifs and partially inhibits their translation but dissociates following oxidative stress. Required for correct mitochondrial morphology and function and for autophagy of dysfunctional mitochondria. Regulates astrocyte inflammatory responses. Acts as a positive regulator of androgen receptor-dependent transcription. Prevents aggregation of SNCA. Plays a role in fertilization. Has no proteolytic activity. Has cell-growth promoting activity and transforming activity. May function as a redox-sensitive chaperone.<ref>PMID:9070310</ref> <ref>PMID:11477070</ref> <ref>PMID:12612053</ref> <ref>PMID:14749723</ref> <ref>PMID:15502874</ref> <ref>PMID:15976810</ref> <ref>PMID:16390825</ref> <ref>PMID:17015834</ref> <ref>PMID:18626009</ref> <ref>PMID:18711745</ref> <ref>PMID:20304780</ref> <ref>PMID:21097510</ref> <ref>PMID:12939276</ref> <ref>PMID:15181200</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
DJ-1 (PARK7) is an intensively studied protein whose cytoprotective activities are dysregulated in multiple diseases. DJ-1 has been reported as having two distinct enzymatic activities in defense against reactive carbonyl species that are difficult to distinguish in conventional biochemical experiments. Here, we establish the mechanism of DJ-1 using a synchrotron-compatible version of mix-and-inject-serial crystallography (MISC), which was previously performed only at XFELs, to directly observe DJ-1 catalysis. We designed and used new diffusive mixers to collect time-resolved Laue diffraction data of DJ-1 catalysis at a pink beam synchrotron beamline. Analysis of structurally similar methylglyoxal-derived intermediates formed through the DJ-1 catalytic cycle shows that the enzyme catalyzes nearly two turnovers in the crystal and defines key aspects of its glyoxalase mechanism. In addition, DJ-1 shows allosteric communication between a distal site at the dimer interface and the active site that changes during catalysis. Our results rule out the widely cited deglycase mechanism for DJ-1 action and provide an explanation for how DJ-1 produces L-lactate with high chiral purity.
-
Authors: Zielinski, K.A., Dolamore, C., Dalton, K., Meisburger, S.P., Smith, N., Termini, J., Henning, R., Srajer, V., Hekstra, D., Pollack, L., Wilson, M.A.
+
Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron.,Zielinski KA, Dolamore C, Dalton KM, Smith N, Termini J, Henning R, Srajer V, Hekstra DR, Pollack L, Wilson MA bioRxiv [Preprint]. 2024 Jul 20:2024.07.19.604369. doi: , 10.1101/2024.07.19.604369. PMID:39071394<ref>PMID:39071394</ref>
-
Description: Human DJ-1, 30 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
-
[[Category: Hekstra, D]]
+
<div class="pdbe-citations 9cg0" style="background-color:#fffaf0;"></div>
-
[[Category: Meisburger, S.P]]
+
== References ==
-
[[Category: Smith, N]]
+
<references/>
-
[[Category: Henning, R]]
+
__TOC__
-
[[Category: Wilson, M.A]]
+
</StructureSection>
-
[[Category: Zielinski, K.A]]
+
[[Category: Homo sapiens]]
-
[[Category: Termini, J]]
+
[[Category: Large Structures]]
-
[[Category: Dalton, K]]
+
[[Category: Dalton K]]
-
[[Category: Pollack, L]]
+
[[Category: Dolamore C]]
-
[[Category: Srajer, V]]
+
[[Category: Hekstra D]]
-
[[Category: Dolamore, C]]
+
[[Category: Henning R]]
 +
[[Category: Meisburger SP]]
 +
[[Category: Pollack L]]
 +
[[Category: Smith N]]
 +
[[Category: Srajer V]]
 +
[[Category: Termini J]]
 +
[[Category: Wilson MA]]
 +
[[Category: Zielinski KA]]

Current revision

Human DJ-1, 30 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography

PDB ID 9cg0

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/9cg0"
Personal tools